Seroprevalence of SARS-CoV-2 Antibodies in Denmark: Results of Two Nationwide Population-Based Surveys, February and May 2021

References

• Bergeri I, Whelan M, Ware H, et al. Global epidemiology of SARS-CoV-2 infection: a systematic review and meta-analysis of standardized population-based seroprevalence studies. PLOS Medicine. 2022;(11):e1004107. doi:10.1371/JOURNAL.PMED.1004107
   PubMed Web of Science ®Google Scholar
• Arora RK, Joseph A, Van Wyk J, et al. SeroTracker: a global SARS-CoV-2 seroprevalence dashboard. Lancet Infect Dis. 2021;21:e75–e76. doi:10.1016/S1473-3099(20)30631-9
   PubMed Web of Science ®Google Scholar
• Rostami A, Sepidarkish M, Leeflang MMG, et al. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis. 2021;27(3):331–340.
   PubMed Web of Science ®Google Scholar
• Rostami A, Sepidarkish M, Fazlzadeh A, et al. Update on SARS-CoV-2 seroprevalence: regional and worldwide. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis. 2021;27(12):1762–1771.
   PubMed Web of Science ®Google Scholar
• Bobrovitz N, Arora RK, Cao C, et al. Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis. PLoS One. 2021;16(6):e0252617. doi:10.1371/journal.pone.0252617
   PubMed Web of Science ®Google Scholar
• Lewis H, Ware H, Whelan M, et al. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021. BMJ Global Health. 2022;(7):e008793. doi:10.1136/bmjgh-2022-008793
   PubMedGoogle Scholar
• Murhekar MV, Bhatnagar T, Thangaraj JWV, et al. Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: a population-based cross-sectional study. PLoS Med. 2021;18(12):e1003877. doi:10.1371/journal.pmed.1003877
   PubMed Web of Science ®Google Scholar
• Jones JM, Stone M, Sulaeman H, et al. Estimated US infection- and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations. J Am Med Assoc. 2021;326(14):1400–1409. doi:10.1001/jama.2021.15161
   PubMed Web of Science ®Google Scholar
• Leclercq V, Van den Houte N, Gisle L, et al. Prevalence of anti-SARS-CoV-2 antibodies and potential determinants among the Belgian adult population: baseline results of a prospective cohort study. Viruses. 2022;14(5):920. doi:10.3390/v14050920
   PubMed Web of Science ®Google Scholar
• Gornyk D, Harries M, Glöckner S, et al. SARS-CoV-2 Seroprevalence in Germany. Dtsch Arztebl Int. 2021;118:48.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Kwatra G, Myers JE, et al. Population immunity and covid-19 severity with omicron variant in South Africa. N Engl J Med. 2022;386(14):1314–1326. doi:10.1056/NEJMoa2119658
   PubMed Web of Science ®Google Scholar
• COVID-19 seroprevalence study [Prævalensundersøgelse af covid-19]; 2022. Danish. Available from: https://covid19.ssi.dk/overvagningsdata/undersoegelser/praevalensundersogelsen. Accessed December 29, 2022.
   Google Scholar
• Espenhain L, Tribler S, Sværke Jørgensen C, Holm Hansen C, Wolff Sönksen U, Ethelberg S. Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study. Eur J Epidemiol. 2021;36(7):715–725. doi:10.1007/s10654-021-00796-8
   PubMed Web of Science ®Google Scholar
• Munch PK, Espenhain L, Hansen CH, Krause TG, Ethelberg S. Case-control study of activities associated with SARS-CoV-2 infection in an adult unvaccinated population and overview of societal COVID-19 epidemic counter measures in Denmark. PLoS One. 2022;17(11):e0268849. doi:10.1371/journal.pone.0268849
   PubMed Web of Science ®Google Scholar
• Gram MA, Nielsen J, Schelde AB, et al. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: a nationwide population-based cohort study. PLoS Med. 2021;18(12):e1003874. doi:10.1371/journal.pmed.1003874
   PubMed Web of Science ®Google Scholar
• Michlmayr D, Hansen CH, Gubbels SM, et al. Observed protection against SARS-CoV-2 reinfection following a primary infection: a Danish cohort study among unvaccinated using two years of nationwide PCR-test data. Lancet Reg Heal Eur. 2022;20:100452. doi:10.1016/j.lanepe.2022.100452
   PubMedGoogle Scholar
• COVID-19 [Internet]; 2022. Available from: https://en.ssi.dk/covid-19. Accessed December 29, 2022.
   Google Scholar
• Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-3
   PubMed Web of Science ®Google Scholar
• Schønning K, Dessau RB, Jensen TG, et al. Electronic reporting of diagnostic laboratory test results from all healthcare sectors is a cornerstone of national preparedness and control of COVID-19 in Denmark. APMIS. 2021;129:438–451. doi:10.1111/apm.13140
   PubMed Web of Science ®Google Scholar
• Hansen CH, Michlmayr D, Gubbels SM, Mølbak K, Ethelberg S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet. 2021;397(10280):1204–1212. doi:10.1016/S0140-6736(21)00575-4
   PubMed Web of Science ®Google Scholar
• Grove Krause T, Jakobsen S, Haarh M, Molbak K. The Danish vaccination register. Euro Surveill Bull Eur Sur Les Mal Transm. 2012;17:17.
   Google Scholar
• Harritshøj LH, Gybel-Brask M, Afzal S, et al. Comparison of 16 serological SARS-CoV-2 immunoassays in 16 clinical laboratories. J Clin Microbiol. 2021;59(5). doi:10.1128/JCM.02596-20
   PubMed Web of Science ®Google Scholar
• Lang Z, Reiczigel J. Confidence limits for prevalence of disease adjusted for estimated sensitivity and specificity. Prev Vet Med. 2014;113(1):13–22. doi:10.1016/j.prevetmed.2013.09.015
   PubMed Web of Science ®Google Scholar
• Kaspersen KA, Hindhede L, Boldsen JK, et al. Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark. J Infect Dis. 2022;225(2):219–228. doi:10.1093/infdis/jiab566
   PubMed Web of Science ®Google Scholar
• Fogh K, Eriksen ARR, Hasselbalch RB, et al. Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark. BMC Infect Dis. 2022;22(1). doi:10.1186/s12879-022-07102-1
   PubMed Web of Science ®Google Scholar
• Ward H, Cooke G, Whitaker M, et al. REACT-2 Round 5: increasing prevalence of SARS-CoV-2 antibodies demonstrate impact of the second wave and of vaccine roll-out in England. medRxiv. 2021;2021:21252512.
   Google Scholar
• Anda EE, Braaten T, Borch KB, et al. Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. medRxiv. 2021. doi:10.1101/2021.03.23.21253730
   Google Scholar
• Contini C, Pearson R, Wang L, et al. Bottom-up evolution from disks to high-genus polymersomes. ChemRxiv. 2018. doi:10.26434/chemrxiv.6108467.v1
   Google Scholar
• Björkander S, Du L, Zuo F, et al. SARS-CoV-2–specific B- and T-cell immunity in a population-based study of young Swedish adults. J Allergy Clin Immunol. 2022;149(1):65–75.e8. doi:10.1016/j.jaci.2021.10.014
   PubMed Web of Science ®Google Scholar
• Piler P, Thon V, Andrýsková L, et al. Nationwide increases in anti-SARS-CoV-2 IgG antibodies between October 2020 and march 2021 in the unvaccinated Czech population. Commun Med. 2022;2:1. doi:10.1038/s43856-022-00080-0
   PubMedGoogle Scholar
• Bühler K-M, Echeverry-Alzate V, Calleja-Conde J, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies: relationship with COVID-19 diagnosis, symptoms, smoking, and method of transmission. IJID Reg. 2022;4:10–16. doi:10.1016/j.ijregi.2022.05.007
   PubMedGoogle Scholar
• Jørgensen F, Bor A, Petersen MB. Compliance without fear: individual-level protective behaviour during the first wave of the COVID-19 pandemic. Br J Health Psychol. 2021;26(2):679–696. doi:10.1111/bjhp.12519
   PubMed Web of Science ®Google Scholar
• Agreement on extension of the first phase of a controlled societal reopening - The Prime Minister. [Aftale vedrørende udvidelse af den første fase af en kontrolleret genåbning – statsministeriet]; 2022. Danish. Available from: https://www.stm.dk/statsministeriet/publikationer/aftale-vedroerende-udvidelse-af-den-foerste-fase-af-en-kontrolleret-genaabning/. Accessed December 29, 2022.
   Google Scholar
• Statens Serum Institut: expert committee report; Design of national representative population survey, 7 May 2020. [Statens Serum Institut: rapport fra ekspertudvalget: stikprøvedesign til en løbende repræsentativ undersøgelse af befolkningen - 7. maj 2020]; 2022. Copenhagen. Danish. Danish: https://files.ssi.dk/Ekspertudvalgsrapportvedrstikprvedesign07052020revideret13052020bg20. Accessed December 29, 2022.
   Google Scholar